Back to Journals » Drug Design, Development and Therapy » Volume 9

The role of taxanes in triple-negative breast cancer: literature review [Corrigendum]

Authors Mustacchi G, De Laurentiis M

Received 7 October 2015

Accepted for publication 7 October 2015

Published 19 October 2015 Volume 2015:9 Pages 5669—5670

DOI https://doi.org/10.2147/DDDT.S97778


Mustacchi G, De Laurentiis M

Mustacchi G, De Laurentiis M. Drug Des Devel Ther. 2015;9:4303–4318.

On page 4315, Disclosure section, "This work was supported by an unconditional grant from Editree editors, Italy, and both authors received a fee. Giorgio Mustacchi receives honoraria from Roche, Celgene, and EISAI. Michelino De Laurentiis receives honoraria from Roche, Celgene, EISAI, Novartis, and AstraZeneca. The authors report no other conflicts of interest in this work." should have read "The authors report no conflict of interest with this work".

Read the original article

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]